Просмотр кода страницы Sex linkage

{{Short description|Sex-specific patterns of inheritance}}
{{Use dmy dates|date=April 2020}}

'''Sex linkage''' describes the sex-specific patterns of [[Heredity|inheritance]] and [[Gene expression|expression]] when a [[gene]] is present on a [[sex chromosome]] (allosome) rather than a non-sex chromosome ([[autosome]]).  Genes situated on the [[X chromosome|X-chromosome]] are thus termed X-linked, and are transmitted by both males and females, while genes situated on the [[Y chromosome|Y-chromosome]] are termed Y-linked, and are transmitted by males only.  As human females possess two X-chromosomes and human males possess one X-chromosome and one Y-chromosome, the phenotype of a sex-linked trait can differ between males and females due to the differential number of [[allele]]s (polymorphisms) possessed for a given gene.  In humans, sex-linked patterns of inheritance are termed [[X-linked recessive]], [[X-linked dominant]] and [[Y-linked]]. The inheritance and presentation of all three differ depending on the sex of both the parent and the child. This makes sex-linked patterns of inheritance characteristically different from autosomal [[dominance and recessiveness]].<ref name="[[Video|]]Sex-Linked">{{Citation |last1=Kumar |first1=Rahul |title=Sex-Linked |date=2020 |encyclopedia=Encyclopedia of Animal Cognition and Behavior |pages=1–4 |editor-last=Vonk |editor-first=Jennifer |url=https://link.springer.com/referenceworkentry/10.1007/978-3-319-47829-6_562-1 |access-date=2025-03-10 |place=Cham |publisher=Springer International Publishing |language=en |doi=10.1007/978-3-319-47829-6_562-1 |isbn=978-3-319-47829-6 |last2=Gautam |first2=Akash |last3=Singh |first3=Shashi Bala |editor2-last=Shackelford |editor2-first=Todd|url-access=subscription }}</ref>  This article will discuss each of these patterns of inheritance, as well as diseases that commonly arise through these sex-linked patterns of inheritance.  Variation in these inheritance patterns arising from [[aneuploidy]] of sex chromosomes, sex-linkage in non-human animals, and the history of the discovery of sex-linked inheritance are briefly introduced.

== Background ==
In humans (and mammals in general), biological sex is determined by genetics. However this is not the case for all organisms. For instance, the biological sex of select reptiles is environmentally determined, and the sex of select worms is dependent on location.<ref>{{cite book |last1=Gilbert |first1=Scott F. |title=Developmental Biology |edition=6th |date=2000 |publisher=Sinauer Associates |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK9989/ |chapter=Environmental Sex Determination }}</ref>

22 of the 23 pairs of human chromosomes are autosomal (not involved in sex determination), while the 23rd pair of human chromosomes are the sex chromosomes.  The possession of two X-chromosomes defines a biological female, while the possession of one X and one Y chromosome defines a biological male.<ref>{{cite book |last1=Gilbert |first1=Scott F. |title=Developmental Biology |edition=6th |date=2000 |publisher=Sinauer Associates |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK9967/ |chapter=Chromosomal Sex Determination in Mammals}}</ref> The two sex chromosomes differ in size and gene content, and unlike the sets of autosomal chromosomes, are not homologous.  The [[X chromosome|X-chromosome]] contains an estimated 1400 genes, most of which are involved in tissue development and the development of human disorders.<ref>{{cite book |last1=Information (US) |first1=National Center for Biotechnology |title=Genes and Disease [Internet] |date=1998 |publisher=National Center for Biotechnology Information (US) |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK22266/ |chapter=Chromosome Map }}</ref><ref>{{cite book |last1=Basta |first1=Marina |last2=Pandya |first2=Ashish M. |title=StatPearls |date=2025 |publisher=StatPearls Publishing |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK557383/ |chapter=Genetics, X-Linked Inheritance |pmid=32491315 }}</ref>  The [[Y chromosome|Y-chromosome]] is host to the SRY gene, which is involved in the development of several male sex characteristics, while the identified functions of many of the remaining approximately 200 genes on the Y-chromosome are associated with human disease.<ref>{{Cite web |title=Y Chromosome |url=https://www.genome.gov/about-genomics/fact-sheets/Y-Chromosome-facts#:~:text=The%20Y%20chromosome%20is%20one,is%20frequently%20used%20in%20genealogy |access-date=2025-02-14 |website=www.genome.gov |language=en}}</ref> Sex linkage thus refers to the association of a trait encoded by one of the genes on these sex chromosomes.  There are many more X-linked conditions than Y-linked conditions due to the larger size of the X-chromosome and greater number of genes encoded within it.<ref name="[[Video|]]Sex-Linked" />

In [[classical genetics]], a mating experiment called a [[reciprocal cross]] is performed to test if an animal's trait is sex-linked.<ref>{{Cite book |last1=Gai |first1=J |title=Brenner's Encyclopedia of Genetics |last2=He |first2=J |date=2013 |publisher=Academic Press |isbn=978-0-08-096156-9 |edition=2nd |pages=66–67}}</ref>

== X-linked patterns of inheritance ==
A disease or trait determined by a gene on the X-chromosome demonstrates X-linked inheritance.  Historically, X-linked inheritance has been divided into the patterns of X-linked dominant inheritance and X-linked recessive inheritance as synonymous with classical [[Mendelian inheritance]] of genes on [[Autosome|autosomal]] chromosomes.<ref>{{Citation |last1=Basta |first1=Marina |title=Genetics, X-Linked Inheritance |date=2025 |work=StatPearls |url=https://www.ncbi.nlm.nih.gov/books/NBK557383/ |access-date=2025-03-21 |place=Treasure Island (FL) |publisher=StatPearls Publishing |pmid=32491315 |last2=Pandya |first2=Ashish M.}}</ref> However, more recently scholars have suggested the discontinuation of the use of the terms ''dominant'' and ''recessive'' when referring to X-linked inheritance, stating that the highly variable penetrance of X-linked traits in females as a result of mechanisms such as [[skewed X-inactivation]] or [[somatic mosaicism]] is difficult to reconcile with standard definitions of dominance and recessiveness.<ref>{{cite journal |last1=Dobyns |first1=William B. |last2=Filauro |first2=Allison |last3=Tomson |first3=Brett N. |last4=Chan |first4=April S. |last5=Ho |first5=Allen W. |last6=Ting |first6=Nicholas T. |last7=Oosterwijk |first7=Jan C. |last8=Ober |first8=Carole |date=30 August 2004 |title=Inheritance of most X-linked traits is not dominant or recessive, just X-linked |journal=American Journal of Medical Genetics Part A |volume=129A |issue=2 |pages=136–143 |doi=10.1002/ajmg.a.30123 |pmid=15316978}}</ref>
{| align=center style="border: 1px solid gray; background-color: #fdffe7;"
|(A) [[File:X dominant affected father.svg|300px]]
||(B) [[File:X dominant affected mother.svg|300px]]
||(C) [[File:X recessive carrier mother.svg|300px]]
|}
{| align="center" ←legend -->
|<small>'''Illustration of some X-linked heredity outcomes''' (A) the affected father has one X-linked dominant allele, the mother is [[Zygosity#Homozygous|homozygous]] for the recessive allele: only daughters (all) will be affected. (B) the affected mother is [[Zygosity#Heterozygous|heterozygous]] with one copy of the X-linked dominant allele: both daughters and sons will have 50% probability to be affected. (C) the heterozygous mother is called "carrier" because she has one copy of the recessive allele: sons will have 50% probability to be affected, 50% of unaffected daughters will become carriers like their mother.<ref>Genetics home reference (2006), [http://ghr.nlm.nih.gov/handbook/Inheriting genetic conditions illustrations]{{dead link|date=July 2025|bot=medic}}{{cbignore|bot=medic}}, [[National Library of Medicine]].</ref></small>
|-
|}

==X-linked dominant inheritance==
[[File:X-linked dominant (affected mother).svg|thumb|The phenotype of an X-linked dominant trait is exhibited by both males and females, and requires only one copy of the affected allele.|396x396px]]'''X-linked dominant inheritance''' is the pattern by which a trait encoded by an allele on the X-chromosome is passed down through generations, wherefore only one copy of that allele is sufficient for an individual to be affected ([[Dominance (genetics)|dominance]]).<ref>{{Cite web |date=March 21, 2025 |title=NCI Dictionary of Genetics Terms |url=https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/x-linked-dominant-inheritance |website=National Cancer Institute}}</ref>  Unlike with [[X-linked recessive]] traits, females are more often affected by X-linked dominant traits than males as females have two X-chromosomes as opposed to one.  Moreover, some X-linked dominant conditions (for example, [[Aicardi syndrome]]) are embryonically or neonatally lethal in hemizygous males (XY), and thus can be seen to only affect heterozygous females, who experience less severe symptoms.<ref>{{Cite book |last=Waxman |first=Stephen G. |title=Molecular Neurology |date=2010 |publisher=Elsevier Science |isbn=978-0-12-369509-3 |location=Burlington}}</ref>

=== Frequency and patterns of inheritance ===
In X-linked dominant inheritance, the transmission of the gene depends on the genotype of each of the parents.  A mother heterozygous for an X-linked dominant trait will be affected, and half of her children (whether female or male) will inherit her affected X-chromosome and be affected themselves, assuming an unaffected father.  Of the children of a father affected by an X-linked dominant trait and an unaffected mother, all daughters will be affected (having inherited their father's only affected X-chromosome), while no sons will be affected (having received their father's Y-chromosome).  A child affected by an X-linked dominant condition will always have at least one affected parent, and an affected son will always have an affected mother.<ref>{{Cite web |title=Sex(X)-linked Dominant Inheritance – Michigan Genetics Resource Center |url=https://migrc.org/teaching-tools/genetic-inheritance-patterns/sexx-linked-dominant/ |access-date=2025-03-21 |language=en-US}}</ref><ref>{{Cite web |title=Sex-linked dominant: MedlinePlus Medical Encyclopedia |url=https://medlineplus.gov/ency/article/002050.htm#:~:text=Sex-linked%20dominant%20is%20a,Autosomal%20dominant |access-date=2025-03-21 |website=medlineplus.gov |language=en}}</ref>

==X-linked recessive inheritance==
[[File:X-linked recessive (2).svg|thumb|In X-linked recessive inheritance, males can only inherit the trait from the mother, and females can be carriers as a result of a carrier mother or affected father.|403x403px]]
[[X-linked recessive inheritance]] describes one of the patterns of inheritance of genetic traits or disorders encoded by an [[allele]] (version of a gene) situated on the X-chromosome.  In X-linked recessive inheritance, females (XX) must have two copies of the allele (homozygous), while males (XY) require only one copy of the allele (hemizygous) to display the phenotype.  Thus, it is far more common for males to be affected by X-linked recessive traits.<ref name="medlineplus.gov">{{Cite web |title=What are the different ways a genetic condition can be inherited?: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/understanding/inheritance/inheritancepatterns/ |access-date=2025-03-10 |website=medlineplus.gov |language=en}}</ref><ref>{{cite book |title=Understanding Genetics: A New York, Mid-Atlantic Guide for Patients and Health Professionals |date=8 July 2009 |publisher=Genetic Alliance |chapter=Inheritance Patterns |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK115561/}}</ref>

A female heterozygous for an X-linked recessive trait is considered a [[Hereditary carrier|carrier]].<ref name="Genetics, X-Linked Inheritance">{{Citation |last1=Basta |first1=Marina |title=Genetics, X-Linked Inheritance |date=2025 |work=StatPearls |url=https://www.ncbi.nlm.nih.gov/books/NBK557383/ |access-date=2025-03-10 |place=Treasure Island (FL) |publisher=StatPearls Publishing |pmid=32491315 |last2=Pandya |first2=Ashish M.}}</ref>  While a carrier female most often does not display the phenotype, rare cases of skewed [[X-inactivation|X-chromosome inactivation]], can lead to varied levels of expression.  This would occur when, during the normal process of inactivating half of a female's X-chromosomes, inactivation preferentially targets X-chromosomes inherited from a single parent,  thus the remaining active X-chromosomes from the other parent are disproportionately expressed.<ref>{{Cite journal |last1=Shvetsova |first1=Ekaterina |last2=Sofronova |first2=Alina |last3=Monajemi |first3=Ramin |last4=Gagalova |first4=Kristina |last5=Draisma |first5=Harmen H. M. |last6=White |first6=Stefan J. |last7=Santen |first7=Gijs W. E. |last8=Chuva de Sousa Lopes |first8=Susana M. |last9=Heijmans |first9=Bastiaan T. |last10=van Meurs |first10=Joyce |last11=Jansen |first11=Rick |last12=Franke |first12=Lude |last13=Kiełbasa |first13=Szymon M. |last14=den Dunnen |first14=Johan T. |last15='t Hoen |first15=Peter A. C. |date=2018-12-14 |title=Skewed X-inactivation is common in the general female population |journal=European Journal of Human Genetics |volume=27 |issue=3 |pages=455–465 |doi=10.1038/s41431-018-0291-3 |pmid=30552425 |pmc=6460563 }}</ref>

There are characteristic patterns for X-linked recessive inheritance.  As each parent contributes one sex chromosome to their offspring, sons cannot receive the X-linked trait from affected fathers, who provide only a Y-chromosome.  Consequently, affected males must inherit the X-linked recessive trait from their mothers.  Sons of a healthy carrier female have a 50% change of being affected, while sons of an affected female will always be affected.  Females must inherit a X-linked recessive allele from each parent.  All daughters of an affected father and healthy non-carrier mother will be carriers.  Daughters of an affected father and carrier mother will have a 50% chance of being affected, and daughters of two affected parents will always be affected.<ref name="Genetics, X-Linked Inheritance"/><ref>{{Cite web |title=Sex-linked recessive: MedlinePlus Medical Encyclopedia |url=https://medlineplus.gov/ency/article/002051.htm |access-date=2025-03-10 |website=medlineplus.gov |language=en}}</ref>  While there is no male-to-male transmission of X-linked recessive traits, an affected male can pass his recessive X allele to a grandson through his unaffected carrier daughter.<ref name="medlineplus.gov"/>

== X-linked diseases ==

=== X-linked dominant diseases ===
* [[Aicardi syndrome]]
* [[Alport syndrome]]<ref>{{cite journal |last1=Jais |first1=Jean Philippe |last2=Knebelmann |first2=Bertrand |last3=Giatras |first3=Iannis |last4=De Marchi |first4=Mario |last5=Rizzoni |first5=Gianfranco |last6=Renieri |first6=Alessandra |last7=Weber |first7=Manfred |last8=Gross |first8=Oliver |last9=Netzer |first9=Kai-Olaf |last10=Flinter |first10=Frances |last11=Pirson |first11=Yves |last12=Dahan |first12=Karin |last13=Wieslander |first13=Jörgen |last14=Persson |first14=Ulf |last15=Tryggvason |first15=Karl |last16=Martin |first16=Paula |last17=Hertz |first17=Jens Michael |last18=Schröder |first18=Cornelis |last19=Sanak |first19=Marek |last20=Carvalho |first20=Maria Fernanda |last21=Saus |first21=Juan |last22=Antignac |first22=Corinne |last23=Smeets |first23=Hubert |last24=Gubler |first24=Marie Claire |title=X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A 'European Community Alport Syndrome Concerted Action' Study |journal=Journal of the American Society of Nephrology |date=October 2003 |volume=14 |issue=10 |pages=2603–2610 |doi=10.1097/01.ASN.0000090034.71205.74 |pmid=14514738 |hdl=2078.1/40773 |hdl-access=free }}</ref> (majority of cases)
* [[Coffin–Lowry syndrome]] (CLS)
* [[Fragile-X syndrome]]
* [[Goltz syndrome]]
* [[Idiopathic hypoparathyroidism]]
* [[Incontinentia pigmenti]]<ref>{{cite book |doi=10.1007/978-3-540-29676-8_942 |chapter=Incontinentia Pigmenti |title=Encyclopedia of Molecular Mechanisms of Disease |date=2009 |last1=Gartler |first1=Stanley M. |last2=Hansen |first2=R. Scott |last3=Oji |first3=Vinzenz |last4=Traupe |first4=Heiko |last5=Horn |first5=Julia |last6=Grimbacher |first6=Bodo |last7=Sen-Chowdhry |first7=Srijita |last8=Ward |first8=Deirdre |last9=McKenna |first9=William J. |last10=Lai |first10=Kar Neng |last11=Hofmann |first11=Silke |last12=Bruckner-Tuderman |first12=Leena |last13=Schwarz |first13=Peter E. H. |last14=Li |first14=Jiang |last15=Bröer |first15=Stefan |last16=Marshall |first16=Wallace F. |last17=Lavine |first17=Elana |last18=Roifman |first18=Chaim M. |last19=Miyara |first19=Makoto |last20=Sakaguchi |first20=Shimon |last21=Rautenberg |first21=Carla |last22=Grimbacher |first22=Bodo |last23=Holm |first23=Are Martin |last24=Säemann |first24=Marcus D. |last25=Sunderkötter |first25=Cord |last26=Itoi |first26=Eiji |last27=Knirsch |first27=Ursula |last28=Gosztonyi |first28=Georg |last29=Oji |first29=Vinzenz |last30=Traupe |first30=Heiko |pages=1045–1046 |isbn=978-3-540-67136-7 |display-authors=1 }}</ref><ref>{{EMedicine|article|1114205|Incontinentia Pigmenti}}</ref>
* [[Porphyria]]<ref>{{cite journal |last1=Seager |first1=M. J. |last2=Whatley |first2=S. D. |last3=Anstey |first3=A. V. |last4=Millard |first4=T. P. |title=X-linked dominant protoporphyria: a new porphyria |journal=Clinical and Experimental Dermatology |date=2014 |volume=39 |issue=1 |pages=35–37 |doi=10.1111/ced.12202 |pmid=24131146 }}</ref> (2-10% of cases)
* [[Rett syndrome]] (5% of cases)
* [[Vitamin D]] resistant [[rickets]] ([[X-linked hypophosphatemia]])

==== Alport syndrome ====
Alport syndrome is a [[genetic disorder]] that primarily affects the kidneys by damaging the glomeruli, which are tiny filtering units inside the kidneys.<ref name=":16">{{Cite web |title=Alport Syndrome |url=https://www.kidney.org/kidney-topics/alport-syndrome |access-date=2025-03-28 |website=www.kidney.org |language=en}}</ref>

It is caused by inherited [[mutation]]s in the [[COL4A3|''COL''4A3]], ''[[COL4A4]]'', and ''[[COL4A5]]'' genes, which are responsible for producing [[type IV collagen]].<ref name=":16" /> These mutations disrupt the formation of basement membranes, particularly in the [[kidney]]s, inner [[ear]]s, and [[Human eye|eyes]], where this collagen network plays a key structural role.<ref>{{Cite journal |last1=Nozu |first1=Kandai |last2=Nakanishi |first2=Koichi |last3=Abe |first3=Yoshifusa |last4=Udagawa |first4=Tomohiro |last5=Okada |first5=Shinichi |last6=Okamoto |first6=Takayuki |last7=Kaito |first7=Hiroshi |last8=Kanemoto |first8=Katsuyoshi |last9=Kobayashi |first9=Anna |last10=Tanaka |first10=Eriko |last11=Tanaka |first11=Kazuki |last12=Hama |first12=Taketsugu |last13=Fujimaru |first13=Rika |last14=Miwa |first14=Saori |last15=Yamamura |first15=Tomohiko |date=February 2019 |title=A review of clinical characteristics and genetic backgrounds in Alport syndrome |journal=Clinical and Experimental Nephrology |volume=23 |issue=2 |pages=158–168 |doi=10.1007/s10157-018-1629-4 |issn=1437-7799 |pmc=6510800 |pmid=30128941}}</ref> The specific gene affected determines the form of Alport syndrome: mutations in COL4A5 cause the X-linked form (XLAS), while mutations in COL4A3 or COL4A4, located on chromosome 2, are associated with autosomal recessive (ARAS) or autosomal dominant (ADAS) forms.<ref>{{Cite web |last=Zaunbrecher |first=Nicole |title=Types of Alport Syndrome - Alport Syndrome News |url=https://alportsyndromenews.com/types-of-alport-syndrome/ |access-date=2025-03-28 |website=alportsyndromenews.com |language=en-US}}</ref>

Common signs and symptoms of Alport syndrome include [[hematuria]] (blood in urine), [[proteinuria]] (protein in urine), hearing loss, and eye abnormalities.<ref>{{Cite web |title=Alport syndrome: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/alport-syndrome/ |access-date=2025-03-28 |website=medlineplus.gov |language=en}}</ref>

Diagnosis typically involves urine and blood tests, hearing and vision assessments, and genetic testing to confirm the mutation and identify the specific type of Alport syndrome. Kidney biopsy can reveal a characteristic 'basketweave' appearance of the glomerular basement membrane under electron microscopy.<ref>{{Citation |last1=Nozu |first1=Kandai |title=Alport Syndrome |date=1993 |work=GeneReviews® |editor-last=Adam |editor-first=Margaret P. |url=https://www.ncbi.nlm.nih.gov/books/NBK1207/ |access-date=2025-03-28 |place=Seattle (WA) |publisher=University of Washington, Seattle |pmid=20301386 |last2=Yamamura |first2=Tomohiko |last3=Horinouchi |first3=Tomoko |editor2-last=Feldman |editor2-first=Jerry |editor3-last=Mirzaa |editor3-first=Ghayda M. |editor4-last=Pagon |editor4-first=Roberta A.}}</ref> In some cases, skin or kidney tissue may be tested for the absence of type IV collagen proteins. [[Genetic testing]] is especially useful when biopsy is inconclusive or unavailable.

While there is no cure, treatments focus on slowing the progression of the kidney disease and managing symptoms. [[ACE inhibitor]]s are commonly used to control blood pressure and reduce proteinuria.<ref>{{Cite journal |date=2024-08-02 |title=Alport Syndrome Treatment & Management: Approach Considerations, Monitoring, Kidney Transplantation |url=https://emedicine.medscape.com/article/238260-treatment?form=fpf}}</ref> If kidney failure develops, [[Kidney dialysis|dialysis]] or [[Kidney transplantation|kidney transplant]] is often effective. Rarely, transplant recipients may develop anti-GBM disease due to antibodies against type IV collagen.<ref>{{Cite web |date=2016-02-10 |title=EdRen - Edinburgh Royal Infirmary Renal Unit - Alport anti-GBM disease |url=http://www.edren.org/pages/edreninfo/alport-syndrome/alport-anti-gbm-disease.php |access-date=2025-03-28 |archive-url=https://web.archive.org/web/20160210041423/http://www.edren.org/pages/edreninfo/alport-syndrome/alport-anti-gbm-disease.php |archive-date=10 February 2016 }}</ref>

==== Fragile X syndrome ====
Fragile X syndrome is a [[Genetic disorder|genetic]] [[neurodevelopmental disorder]] caused by a CGG [[Trinucleotide repeat disorder|trinucleotide repeat]] expansion in the ''[[FMR1]]'' [[gene]] on the [[X chromosome]].<ref>{{Cite web |title=Fragile X syndrome: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/fragile-x-syndrome/#causes |access-date=2025-03-29 |website=medlineplus.gov |language=en}}</ref> It is inherited in an X-linked dominant pattern and is the most common known inherited genetic cause of [[autism spectrum disorder]].<ref name=":17">{{Cite journal |last1=McLennan |first1=Yingratana |last2=Polussa |first2=Jonathan |last3=Tassone |first3=Flora |last4=Hagerman |first4=Randi |date=May 2011 |title=Fragile x syndrome |journal=Current Genomics |volume=12 |issue=3 |pages=216–224 |doi=10.2174/138920211795677886 |issn=1875-5488 |pmc=3137006 |pmid=22043169}}</ref> The condition affects approximately 1 in 3,600 males and 1 in 4,000 to 6,000 females.<ref>{{Cite web |date=2012-10-20 |title=Genes and human disease |url=http://www.who.int/genomics/public/geneticdiseases/en/index2.html |access-date=2025-03-29 |archive-url=https://web.archive.org/web/20121020153249/http://www.who.int/genomics/public/geneticdiseases/en/index2.html |archive-date=20 October 2012 }}</ref>

Fragile X syndrome occurs when the CGG repeat expansion exceeds 200 repeats, causing [[methylation]] and silencing of the ''FMR1'' gene. This leads to a deficiency of FMRP, a protein essential for normal synaptic development and brain plasticity.<ref name=":17" />

Fragile X syndrome typically presents with [[learning disabilities]] to severe [[Intellectual disability|intellectual impairment]], along with distinct physical features such as a long face, large or [[protruding ear]]s, [[flat feet]], and [[low muscle tone]].<ref name=":17" /> Many individuals, especially males, also exhibit behavioural traits including [[social anxiety]], [[hyperactivity]], hand-flapping, and self-injurious behaviors such as biting. Females, who have two X chromosomes, are generally less severely affected due to X-inactivation.<ref>{{Cite journal |last1=Bartholomay |first1=Kristi L. |last2=Lee |first2=Cindy H. |last3=Bruno |first3=Jennifer L. |last4=Lightbody |first4=Amy A. |last5=Reiss |first5=Allan L. |date=2019-01-12 |title=Closing the Gender Gap in Fragile X Syndrome: Review on Females with FXS and Preliminary Research Findings |journal=Brain Sciences |volume=9 |issue=1 |page=11 |doi=10.3390/brainsci9010011 |doi-access=free |issn=2076-3425 |pmc=6356553 |pmid=30642066}}</ref>

Diagnosis typically involves identifying a mutation in the ''FMR1'' gene using [[polymerase chain reaction]] (PCR) and [[Southern blot]] analysis to measure CGG repeat expansions and methylation status.<ref>{{Cite journal |last1=Garber |first1=Kathryn B. |last2=Visootsak |first2=Jeannie |last3=Warren |first3=Stephen T. |date=June 2008 |title=Fragile X syndrome |journal=European Journal of Human Genetics |volume=16 |issue=6 |pages=666–672 |doi=10.1038/ejhg.2008.61 |issn=1018-4813 |pmc=4369150 |pmid=18398441}}</ref> Earlier [[cytogenetic]] methods, such as detecting "[[fragile site]]s" on the X chromosome, have largely been replaced due to low reliability, particularly in females.<ref>{{Cite journal |last=Hogan |first=Andrew J. |date=2012-06-01 |title=Visualizing carrier status: Fragile X syndrome and genetic diagnosis since the 1940s |journal=Endeavour |volume=36 |issue=2 |pages=77–84 |url=https://zenodo.org/records/894526 |doi=10.1016/j.endeavour.2011.12.002|pmid=22257912 }}</ref> Early diagnosis is important to support timely intervention and genetic counseling.

==== Rett syndrome ====
Rett syndrome is a severe neurodevelopmental disorder that primarily affects females, with a prevalence of approximately 1 in 8,500.<ref name=":18">{{Cite web |title=Rett syndrome: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/rett-syndrome/ |access-date=2025-03-29 |website=medlineplus.gov |language=en}}</ref> It is caused by mutations in the ''[[MECP2]]'' gene located on the X chromosome and is inherited in an X-linked dominant pattern.<ref name=":18" /> However, the vast majority (over 99%) of cases result from [[De novo mutation|''de novo'' mutations]], often from the paternal germline.<ref>{{Cite journal |last1=Trappe |first1=R. |last2=Laccone |first2=F. |last3=Cobilanschi |first3=J. |last4=Meins |first4=M. |last5=Huppke |first5=P. |last6=Hanefeld |first6=F. |last7=Engel |first7=W. |date=May 2001 |title=MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin |journal=American Journal of Human Genetics |volume=68 |issue=5 |pages=1093–1101 |doi=10.1086/320109 |issn=0002-9297 |pmc=1226090 |pmid=11309679}}</ref>

Following a period of seemingly normal development, Rett syndrome progresses through four clinical stages. Stage I, or early-onset, typically begins between 6 and 18 months of age with subtle developmental delays.<ref name=":19">{{Cite web |date=2017-10-14 |title=Rett Syndrome Fact Sheet |url=https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Rett-Syndrome-Fact-Sheet |access-date=2025-03-29 |archive-url=https://web.archive.org/web/20171014183306/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Rett-Syndrome-Fact-Sheet |archive-date=2017-10-14}}</ref> Stage II,  the rapid destructive phase, involves a sudden loss of purposeful hand use and spoken language, often accompanied by repetitive hand movements, breathing irregularities, and autistic-like behaviours.<ref name=":19" /> In Stage III, or the plateau phase, some behavioural improvements may occur, though motor dysfunction, [[apraxia]], and [[seizure]]s remain common.<ref name=":19" /> Stage IV, the late motor deterioration phase, is characterized by progressive loss of mobility and muscle rigidity, while communication and cognition generally stabilize.<ref name=":19" />

The condition is rarely seen in males, as those with ''[[MECP2]]'' mutations typically do not survive infancy unless they have [[Klinefelter's syndrome]] or [[Mosaic (genetics)|mosaicism]].<ref name=":18" /><ref>{{Cite journal |last1=Schwartzman |first1=J. S. |last2=Bernardino |first2=Andrea |last3=Nishimura |first3=Agnes |last4=Gomes |first4=Raquel R. |last5=Zatz |first5=Mayana |date=June 2001 |title=Rett Syndrome in a Boy with a 47,XXY Karyotype Confirmed by a Rare Mutation in the MECP2 Gene |url=https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-2001-16620 |journal=Neuropediatrics |language=en |volume=32 |issue=3 |pages=162–164 |doi=10.1055/s-2001-16620 |pmid=11521215 |issn=0174-304X|url-access=subscription }}</ref> In contrast, affected females often survive into middle age, with symptom severity influenced by the specific mutation and patterns of X-chromosome inactivation.

Diagnosis is based on clinical presentation and confirmed through genetic testing for ''[[MECP2]]'' mutations once the established diagnostic criteria are met.<ref>{{Cite web |title=A rare genetic neurological and developmental disorder-Rett syndrome - Diagnosis & treatment |url=https://www.mayoclinic.org/diseases-conditions/rett-syndrome/diagnosis-treatment/drc-20377233 |access-date=2025-03-30 |website=Mayo Clinic |language=en}}</ref><ref>{{Cite web |title=Diagnosing & Testing Rett Syndrome |url=https://www.rettsyndrome.org/about-rett-syndrome/diagnosing-and-testing-rett-syndrome/ |access-date=2025-03-30 |website=International Rett Syndrome Foundation |language=en}}</ref> While there is no cure, treatment focuses on managing symptoms with physical and speech therapy, medications for seizures, and supportive care.<ref name=":19" /> In 2023, [[trofinetide]] became the first medication approved in the United States specifically for Rett syndrome.<ref>{{Cite journal |last=Research |first=Center for Drug Evaluation and |date=2023-03-20 |title=FDA approves first treatment for Rett Syndrome |url=https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-rett-syndrome |archive-url=https://web.archive.org/web/20230313153136/http://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-rett-syndrome |archive-date=13 March 2023 |journal=FDA |language=en}}</ref>

==== X-linked hypophosphatemia (vitamin D resistant rickets) ====
X-linked hypophosphatemia is a rare genetic form of [[rickets]] caused by mutations in the ''[[PHEX]]'' gene on the X chromosome.<ref>{{Cite journal |last1=Saito |first1=Tasuku |last2=Nishii |first2=Yutaka |last3=Yasuda |first3=Toshiyuki |last4=Ito |first4=Nobuaki |last5=Suzuki |first5=Hisanori |last6=Igarashi |first6=Takashi |last7=Fukumoto |first7=Seiji |last8=Fujita |first8=Toshiro |date=2009-10-01 |title=Familial hypophosphatemic rickets caused by a large deletion in PHEX gene |url=https://academic.oup.com/ejendo/article-abstract/161/4/647/6676297?redirectedFrom=fulltext&login=false |journal=European Journal of Endocrinology |volume=161 |issue=4 |pages=647–651 |doi=10.1530/EJE-09-0261 |pmid=19581284 |issn=0804-4643|url-access=subscription }}</ref> Unlike nutritional rickets, X-linked hypophosphatemia does not respond to vitamin D supplements. Instead, the ''PHEX'' mutation leads to overproduction of the hormone FGF23, which causes the kidneys to waste phosphate and impairs bone mineralization.<ref>{{Citation |last=Carpenter |first=Thomas O. |title=Primary Disorders of Phosphate Metabolism |date=2000 |work=Endotext |editor-last=Feingold |editor-first=Kenneth R. |url=https://www.ncbi.nlm.nih.gov/books/NBK279172/ |access-date=2025-03-30 |place=South Dartmouth (MA) |publisher=MDText.com, Inc. |pmid=25905395 |editor2-last=Ahmed |editor2-first=S. Faisal |editor3-last=Anawalt |editor3-first=Bradley |editor4-last=Blackman |editor4-first=Marc R.}}</ref><ref>{{Cite journal |last1=Barros |first1=Nilana MT |last2=Hoac |first2=Betty |last3=Neves |first3=Raquel L |last4=Addison |first4=William N |last5=Assis |first5=Diego M |last6=Murshed |first6=Monzur |last7=Carmona |first7=Adriana K |last8=McKee |first8=Marc D |date=2013-03-01 |title=Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia |url=https://academic.oup.com/jbmr/article-abstract/28/3/688/7598800?redirectedFrom=fulltext&login=false |journal=Journal of Bone and Mineral Research |volume=28 |issue=3 |pages=688–699 |doi=10.1002/jbmr.1766 |pmid=22991293 |issn=0884-0431}}</ref> Reduced ''PHEX'' enzyme activity allows the accumulation of [[osteopontin]], a mineralization-inhibiting protein, to accumulate in bones and teeth.<ref>{{Cite journal |last1=Boukpessi |first1=Tchilalo |last2=Hoac |first2=Betty |last3=Coyac |first3=Benjamin R. |last4=Leger |first4=Thibaut |last5=Garcia |first5=Camille |last6=Wicart |first6=Philippe |last7=Whyte |first7=Michael P. |last8=Glorieux |first8=Francis H. |last9=Linglart |first9=Agnès |last10=Chaussain |first10=Catherine |last11=McKee |first11=Marc D. |date=2017-02-01 |title=Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia |url=https://www.sciencedirect.com/science/article/abs/pii/S8756328216303520 |journal=Bone |volume=95 |pages=151–161 |doi=10.1016/j.bone.2016.11.019 |pmid=27884786 |issn=8756-3282|url-access=subscription }}</ref> These combined effects result in soft bones (osteomalacia), dental issues (odontomalacia), short stature, and bow-leggedness.<ref>{{Cite journal |last1=McKee |first1=Marc D. |last2=Buss |first2=Daniel J. |last3=Reznikov |first3=Natalie |date=2022-03-01 |title=Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization |url=https://www.sciencedirect.com/science/article/abs/pii/S1047847721001283 |journal=Journal of Structural Biology |volume=214 |issue=1 |article-number=107823 |doi=10.1016/j.jsb.2021.107823 |pmid=34915130 |issn=1047-8477|url-access=subscription }}</ref> The condition affects approximately 1 in 20,000.<ref>{{Cite journal |last=Carpenter |first=Thomas O. |date=1997-04-01 |title=New Perspectives on the Biology and Treatment of X-Linked Hypophosphatemic Rickets |journal=Pediatric Clinics of North America |volume=44 |issue=2 |pages=443–466 |doi=10.1016/S0031-3955(05)70485-5 |issn=0031-3955|doi-access=free |pmid=9130929 }}</ref>

Symptoms vary by age. In children, common signs include [[rickets]], [[fatigue]], delayed growth, [[craniostenosis]] (premature fusion of skull bones), and more.<ref name=":20">{{Cite web |title=Osteomalacia and Rickets |url=https://www.lecturio.com/concepts/osteomalacia-and-rickets/ |access-date=2025-03-30 |website=www.lecturio.com |language=en}}</ref><ref>{{Cite web |title=Fatigue: MedlinePlus Medical Encyclopedia |url=https://medlineplus.gov/ency/article/003088.htm |access-date=2025-03-31 |website=medlineplus.gov |language=en}}</ref><ref>{{Cite web |date=2007-01-07 |title=TheFetus.net - Cloverleaf skull or kleeblattsch?del |first1=Sandra |last1=Silva |first2=Philippe |last2=Jeanty |url=http://thefetus.net/page.php?id=340 |archive-url=https://web.archive.org/web/20070107153006/http://thefetus.net/page.php?id=340 |access-date=2025-03-31 |archive-date=2007-01-07 |website=thefetus.net }}</ref> Adults may experience [[osteomalacia]] (soft bones), fractures or pseudofractures, dental abscesses, hearing loss, and joint pain.<ref name=":20" /><ref>{{Cite web |title=Overview of Bone Fractures |url=https://www.lecturio.com/concepts/overview-of-bone-fractures/ |access-date=2025-03-31 |website=www.lecturio.com |language=en}}</ref><ref>{{Cite journal |last1=Linglart |first1=Agnès |last2=Biosse-Duplan |first2=Martin |last3=Briot |first3=Karine |last4=Chaussain |first4=Catherine |last5=Esterle |first5=Laure |last6=Guillaume-Czitrom |first6=Séverine |last7=Kamenicky |first7=Peter |last8=Nevoux |first8=Jerome |last9=Prié |first9=Dominique |last10=Rothenbuhler |first10=Anya |last11=Wicart |first11=Philippe |last12=Harvengt |first12=Pol |date=2014 |title=Therapeutic management of hypophosphatemic rickets from infancy to adulthood |journal=Endocrine Connections |volume=3 |issue=1 |pages=R13–30 |doi=10.1530/EC-13-0103 |issn=2049-3614 |pmc=3959730 |pmid=24550322}}</ref>

Diagnosis is based on clinical and biochemical findings, including low serum phosphate, elevated alkaline phosphatase, and excessive urinary phosphate loss.<ref>{{Cite journal |last1=Haffner |first1=Dieter |last2=Emma |first2=Francesco |last3=Eastwood |first3=Deborah M. |last4=Biosse Duplan |first4=Martin |last5=Bacchetta |first5=Justine |last6=Schnabel |first6=Dirk |last7=Wicart |first7=Philippe |last8=Bockenhauer |first8=Detlef |last9=Santos |first9=Fernando |last10=Levtchenko |first10=Elena |last11=Harvengt |first11=Pol |last12=Kirchhoff |first12=Martha |last13=Di Rocco |first13=Federico |last14=Chaussain |first14=Catherine |last15=Brandi |first15=Maria Louisa |date=July 2019 |title=Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia |journal=Nature Reviews. Nephrology |volume=15 |issue=7 |pages=435–455 |doi=10.1038/s41581-019-0152-5 |issn=1759-507X |pmc=7136170 |pmid=31068690}}</ref>

Treatment has traditionally included phosphate supplements and active vitamin D analogs.<ref>{{Cite journal |last1=Imel |first1=Erik A. |last2=DiMeglio |first2=Linda A. |last3=Hui |first3=Siu L. |last4=Carpenter |first4=Thomas O. |last5=Econs |first5=Michael J. |date=April 2010 |title=Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations |journal=The Journal of Clinical Endocrinology and Metabolism |volume=95 |issue=4 |pages=1846–1850 |doi=10.1210/jc.2009-1671 |issn=1945-7197 |pmc=2853995 |pmid=20157195}}</ref> More recently, [[burosumab]], a monoclonal antibody that targets FGF23, has been approved and shown to normalize phosphate levels and improve skeletal outcomes in both children and adults.<ref>{{Cite journal |last1=Ewert |first1=Annika |last2=Rehberg |first2=Mirko |last3=Schlingmann |first3=Karl Peter |last4=Hiort |first4=Olaf |last5=John-Kroegel |first5=Ulrike |last6=Metzing |first6=Oliver |last7=Wühl |first7=Elke |last8=Schaefer |first8=Franz |last9=Kemper |first9=Markus J |last10=Derichs |first10=Ute |last11=Richter-Unruh |first11=Annette |last12=Patzer |first12=Ludwig |last13=Albers |first13=Norbert |last14=Dunstheimer |first14=Desiree |last15=Haberland |first15=Holger |date=2023-10-01 |title=Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia |url=https://academic.oup.com/jcem/article/108/10/e998/7142566?login=false |journal=The Journal of Clinical Endocrinology & Metabolism |volume=108 |issue=10 |pages=e998–e1006 |doi=10.1210/clinem/dgad223 |pmid=37097907 |issn=0021-972X|url-access=subscription }}</ref>

=== X-linked recessive diseases ===
The incidence of X-linked recessive conditions in females is the square of that in males. For example, if 1 in 20 males in a human population are [[red–green color blind]], then 1 in 400 females in the population are expected to be color-blind (<sup>1</sup>/<sub>20</sub>)*(<sup>1</sup>/<sub>20</sub>). Examples include:
* [[Aarskog–Scott syndrome]]
* [[Adrenoleukodystrophy]]
* [[Bruton's agammaglobulinemia]]
* [[Color blindness]]
* [[Complete androgen insensitivity syndrome]]
* Congenital [[aqueductal stenosis]] ([[hydrocephalus]])
* [[Duchenne muscular dystrophy]]
* [[Fabry disease]]
* [[Glucose-6-phosphate dehydrogenase deficiency]]
* [[Haemophilia]] [[Haemophilia A|A]] and [[Haemophilia B|B]]
* [[Hunter syndrome]]
* Inherited [[nephrogenic diabetes insipidus]]
* [[Menkes disease]] (kinky hair syndrome)
* [[Ornithine carbamoyltransferase deficiency]]
* [[Wiskott–Aldrich syndrome]]

==== Duchenne muscular dystrophy ====
Duchenne muscular dystrophy is a severe [[neuromuscular disease]] causing progressive weakness and damage of [[Muscle|muscle tissues]],<ref name=":3">{{cite book |last1=Venugopal |first1=Vijay |last2=Pavlakis |first2=Steven |title=StatPearls |date=2025 |publisher=StatPearls Publishing |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK482346/ |chapter=Duchenne Muscular Dystrophy |pmid=29493971 }}</ref> leading to mobility loss and difficulties in daily activities. In a later stage of Duchenne muscular dystrophy, as [[Muscles of respiration|respiratory]] and [[cardiac muscle]]s start to degenerate, affected individuals are likely to develop complications such as [[respiratory failure]], [[cardiomyopathy]] and [[heart failure]].<ref name=":3" /> 1 in 3,600 male births worldwide are affected by Duchenne muscular dystrophy, moreover, it presents itself at around ages 2–4 and progressively worsens.  Most cases of Duchenne muscular dystrophy are inherited from the mother who is a carrier of the X-linked recessive trait, however, approximately 30% occur due to random mutations that are not inherited.<ref name=":13">{{Cite web |date=25 July 2022 |title=Duchenne Muscular Dystrophy (DMD) |url=https://my.clevelandclinic.org/health/diseases/23538-duchenne-muscular-dystrophy-dmd |access-date=22 March 2025 |website=Cleveland Clinic}}</ref>

Duchenne muscular dystrophy arises from a mutation, likely to be the deletion of the [[exon]]s,<ref>{{cite journal |last1=Yiu |first1=Eppie M |last2=Kornberg |first2=Andrew J |title=Duchenne muscular dystrophy |journal=Journal of Paediatrics and Child Health |date=August 2015 |volume=51 |issue=8 |pages=759–764 |doi=10.1111/jpc.12868 |pmid=25752877 }}</ref><ref name=":7">{{Cite journal |last1=Aartsma-Rus |first1=Annemieke |last2=Ginjaar |first2=Ieke B |last3=Bushby |first3=Kate |date=March 2016 |title=The importance of genetic diagnosis for Duchenne muscular dystrophy |journal=Journal of Medical Genetics |volume=53 |issue=3 |pages=145–151 |doi=10.1136/jmedgenet-2015-103387 |pmc=4789806 |pmid=26754139 }}</ref> a [[Nucleic acid sequence|nucleotide sequence]] in the ''DMD'' gene that codes for [[dystrophin]]. Dystrophin is a protein responsible for strengthening and stabilizing muscle fibres.<ref>{{Cite book |last1=Gao |first1=Q. Q. |title=Comprehensive Physiology |last2=McNally |first2=E. M. |date=2011-01-17 |publisher=Wiley |isbn=978-0-470-65071-4 |editor-last=Terjung |editor-first=Ronald |edition=1 |volume=5 |pages=1223–1239 |language=en |doi=10.1002/cphy.c140048 |pmc=4767260 |pmid=26140716 |issue=3}}</ref> With the loss of the dystrophin complex, the muscle cells would no longer be protected and therefore result in progressive damage or degeneration. Although interventions vary case by case, [[corticosteroid]]s are often used to delay the progressive degeneration of muscle cells.<ref name=":13" />

==== X-linked agammaglobulinemia ====
X-linked agammaglobulinemia is a [[Primary immunodeficiency disorders|primary immunodeficiency disorder]] that impairs the body's ability to produce [[Antibody|antibodies]], which are proteins protecting us from disease-causing [[antigen]]s, resulting in severe [[bacterial infections]].<ref name=":2">{{cite book |last1=Smith |first1=CI Edvard |last2=Berglöf |first2=Anna |title=GeneReviews® |date=1993 |publisher=University of Washington, Seattle |chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK1453/ |chapter=X-Linked Agammaglobulinemia |pmid=20301626 }}</ref>

X-linked agammaglobulinemia is associated with a mutation in the ''[[Bruton's tyrosine kinase]]'' (''BTK'') gene, a cytoplasmic signalling molecule, on the X chromosome. The gene is responsible for producing BTK, an [[enzyme]] regulating [[B cell]]s development and maturation within the bone marrow. It is also involved in the further development of the B cells that migrate into the secondary lymphoid tissues like the lymph nodes and spleen.<ref name=":4">{{Cite journal |last1=Maas |first1=A. |last2=Hendriks |first2=R. W. |date=2001 |title=Role of Bruton's tyrosine kinase in B cell development |journal=Developmental Immunology |volume=8 |issue=3–4 |pages=171–181 |doi=10.1155/2001/28962 |pmc=2276078 |pmid=11785667 |doi-access=free}}</ref> B cells are a type of [[white blood cell]]s essential in the production of antibodies, when at an early stage, called [[pre-B cell]]s, they rely on expansion and survival signals involving BTK to mature.<ref>{{Cite journal |last1=McDonald |first1=C. |last2=Xanthopoulos |first2=C. |last3=Kostareli |first3=E. |date=2021 |title=The role of Bruton's tyrosine kinase in the immune system and disease |journal=Immunology |language=en |volume=164 |issue=4 |pages=722–736 |doi=10.1111/imm.13416 |issn=0019-2805 |pmc=8561098 |pmid=34534359}}</ref>

In affected individuals,  their ''BTK'' gene mutations can range from point mutations to [[indel]]s that alter the [[amino acid]] sequence and the structure of BTK making it faulty.<ref name=":4" />  Therefore, the loss of ''BTK'' gene functions, prevents the maturation from pre-B cell to B cell lymphocytes hence, not able to differentiate into [[Antibody|antibodies]]-producing plasma cells. With low antibodies, individuals are highly vulnerable to bacterial and viral infections.<ref>{{Citation |last1=Lackey |first1=Alexandra E. |title=X-Linked Agammaglobulinemia |date=2025 |work=StatPearls |url=https://www.ncbi.nlm.nih.gov/books/NBK549865/ |access-date=2025-03-25 |place=Treasure Island (FL) |publisher=StatPearls Publishing |pmid=31751055 |last2=Ahmad |first2=Faran}}</ref>

==== Red-green colour blindness ====
Red-green colour blindness is a type of [[Color blindness|colour vision deficiency]] caused by a mutation in X-linked genes, affecting [[cone cell]]s responsible for absorbing red or green light.<ref>{{Citation |last1=Carroll |first1=Joseph |title=Chapter 8 - Color vision |date=2021-01-01 |journal=Handbook of Clinical Neurology |volume=178 |pages=131–153 |editor-last=Barton |editor-first=Jason J. S. |url=https://www.sciencedirect.com/science/article/abs/pii/B9780128213773000052 |access-date=2025-03-25 |series=Neurology of Vision and Visual Disorders |publisher=Elsevier |last2=Conway |first2=Bevil R. |doi=10.1016/B978-0-12-821377-3.00005-2 |pmid=33832674 |isbn=978-0-12-821377-3 |editor2-last=Leff |editor2-first=Alexander|url-access=subscription }}</ref> Primarily affecting males (1 in 12) compared to females (1 in 200), as the condition requires all the X chromosomes to have the mutations.<ref>{{Cite web |title=Color vision deficiency: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/color-vision-deficiency/#causes |access-date=2025-03-25 |website=medlineplus.gov |language=en}}</ref>

The perception of red and green light is attributed to the Long (L) and Medium (M) [[wavelength]] cones, respectively.<ref name=":0">{{cite book |doi=10.1016/B978-0-12-821377-3.00005-2 |chapter=Color vision |title=Neurology of Vision and Visual Disorders |series=Handbook of Clinical Neurology |date=2021 |last1=Carroll |first1=Joseph |last2=Conway |first2=Bevil R. |volume=178 |pages=131–153 |pmid=33832674 |isbn=978-0-12-821377-3 }}</ref> In Red-green colour blindness, mutations take place on the ''[[OPN1LW]]'' which impairs L-cones, and ''[[OPN1MW]]'' genes, which impairs the medium cones<ref name=":1">{{cite journal |last1=Deeb |first1=Samir S |title=Molecular genetics of colour vision deficiencies |journal=Clinical and Experimental Optometry |date=July 2004 |volume=87 |issue=4–5 |pages=224–229 |doi=10.1111/j.1444-0938.2004.tb05052.x |pmid=15312026 }}</ref>  coding for the [[photopigments]] in the cones. In milder cases, those affected exhibit reduced sensitivity to red or green light, as a result of [[Hybridization (biology)|hybridization]] of the genes,<ref name=":1" /> shifting the response of one cone towards that of the other.<ref name=":0" /> In the more extreme conditions, there is a deletion or replacement of the respective coding genes,<ref>{{Cite journal |last1=Neitz |first1=J. |last2=Neitz |first2=M. |date=2011 |title=The genetics of normal and defective color vision |url= |journal=Vision Research |language=en |volume=51 |issue=7 |pages=633–651 |doi=10.1016/j.visres.2010.12.002 |pmc=3075382 |pmid=21167193}}</ref> resulting in the absence of L or M cones photopigments and thus losing the ability to differentiate between red or green light completely.

==== Hemophilia A ====
[[Haemophilia A]] is a blood clotting disease caused by a genetic defect in clotting [[factor VIII]]. It causes significant susceptibility to both internal and external bleeding.<ref name=":14" /> 1 in 5,617 live male births is affected, and the condition primarily affects males, while females are usually carriers with mild low [[Coagulation|clotting factor]] level symptoms, due to [[X-inactivation]]. The X-linked mutations are inherited from the mother, however, about ⅓ cases are mutations like [[point mutation]]s or indels that have occurred spontaneously.<ref>{{Cite web |title=Hemophilia A Overview: Symptoms, Genetics, Treatments |url=https://www.bleeding.org/bleeding-disorders-a-z/types/hemophilia-a |access-date=2025-03-25 |website=National Bleeding Disorders Foundation |language=en}}</ref> Mutations in the ''F8'' gene cause hemophilia A, while mutations in the ''F9'' gene cause hemophilia. The ''F8'' gene encodes for [[Factor VIII|coagulation factor VIII]], hence with missing proteins there cannot be effective clotting of the blood.<ref>{{Cite web |title=Hemophilia: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/hemophilia/#causes |access-date=2025-03-25 |website=medlineplus.gov |language=en}}</ref>

Individuals having more severe haemophilia can experience more frequent and intense bleeding, and typically severe hemophilia A affects most patients. Patients with mild haemophilia often do not experience heavy bleeding except for surgeries and significant trauma.<ref name=":14">{{cite book |last1=Konkle |first1=Barbara A. |title=GeneReviews® |last2=Nakaya Fletcher |first2=Shelley |date=1993 |publisher=University of Washington, Seattle |publication-place=Seattle (WA) |page= |chapter=Hemophilia A |pmid=20301578}}</ref>

'''Glucose-6-phosphate dehydrogenase deficiency'''

[[Glucose-6-phosphate dehydrogenase]] (G6PD) deficiency, is characterized by when the enzyme that helps red blood cells to work properly. Without the enzyme red blood cells will prematurely break down leading to [[hemolytic anemia]]. This is a condition that shows a low red blood cell count since the body cannot compensate for the quick degrading cells. Glucose-6-phosphate dehydrogenase is an enzyme that protects red blood cells from oxidative stress caused by [[reactive oxygen species]], it will reduce the amount of ROS accumulation of ROS in the red blood cells. A mutation in the ''G6PD'' gene causes this deficiency, leaving the cells with no protective enzyme. Approximately 400 million individuals have been affected by G6PD deficiency. Since the gene is located on the X- chromosome, therefore, the condition usually affects males more than females. Since males received have the mutated gene on the X-chromosome from the carrier mothers, they tend to show the symptoms of G6PD deficiency. Since females have two X chromosomes, they are typically carriers. However, when the healthy ''G6PD'' gene-carrying chromosome is inactivated females may exhibit mild symptoms.<ref>{{Cite web |title=Glucose-6-phosphate dehydrogenase deficiency: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/glucose-6-phosphate-dehydrogenase-deficiency/#inheritance |access-date=2025-03-25 |website=medlineplus.gov |language=en}}</ref>

'''Wiskott–Aldrich syndrome'''

[[Wiskott–Aldrich syndrome|Wiskott-Aldrich syndrome]] is an X-linked recessive disorder that is caused by mutations in the ''WAS'' gene that encodes for the [[Wiskott–Aldrich syndrome protein|WASp]] protein. It is characterized by weakened [[Immune system|immune function]], [[Dermatitis|eczema]], and problems with blood clotting. This protein is responsible for cell movement and cell-to-cell [[Adhesion (medicine)|adhesions]]. It relays the signals from the surface of all blood cells to the [[Microfilament|actin cytoskeleton]] of the cells to trigger movement and adhesion. When there is the loss of WASp due to the mutation it causes the actin cytoskeleton to not properly form, or not form at all.  In [[white blood cell]]s, this becomes a problem as the lack of actin cytoskeleton does not allow it to respond to the environment and foreign invaders. Therefore, having impaired immune responses causes increased vulnerability to infections and autoimmune diseases. Moreover, a lack of WASp proteins can impair cell growth and induce early cell death. The ''WAS'' gene is located on the X-chromosome, hence primarily affecting the males who inherit the mutated X-chromosome. Females tend to be the carriers and typically do not show symptoms until the healthy X-chromosome is inactivated.<ref>{{Cite web |title=Wiskott-Aldrich syndrome: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/wiskott-aldrich-syndrome/#inheritance |access-date=2025-03-25 |website=medlineplus.gov |language=en}}</ref>

{{X-linked disorders}}

==Screening for genetic diseases==
[[Genetic testing|Genetic screening]], which includes [[Carrier testing|carrier screening]], [[Prenatal testing|prenatal screening]] and [[newborn screening]] may be performed to enable early detection of genetic defects.

=== Carrier screening ===
Carrier screening is conducted on prospective parent(s) to determine if they are [[Hereditary carrier|carriers]] (heterozygous) for an X-linked recessive or autosomal recessive disease.  Individuals who undergo carrier screening commonly have a family history of genetic disease or belong to an at-risk population and wish to determine the likelihood of having a child with a genetic disorder.  Carrier screening is performed by taking a blood sample, saliva sample or [[buccal swab]] and using laboratory techniques such as [[Massive parallel sequencing|next-generation sequencing]] or Polymerase Chain Reaction (PCR) to determine if the parent carries the allele implicated in the genetic disease.<ref>{{Cite journal |last=Antonarakis |first=Stylianos E. |date=September 2019 |title=Carrier screening for recessive disorders |journal=Nature Reviews Genetics |volume=20 |issue=9 |pages=549–561 |doi=10.1038/s41576-019-0134-2 |pmid=31142809 }}</ref><ref>{{Cite book |title=Understanding genetics: a New York, Mid-Atlantic guide for patients and health professionals |date=2009 |publisher=Genetic Alliance |isbn=978-0-9821622-1-7 |editor-last=Genetic Alliance |location=Washington, DC |editor-last2=New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services}}</ref><ref>{{Cite journal |last1=Gregg |first1=Anthony R. |last2=Aarabi |first2=Mahmoud |last3=Klugman |first3=Susan |last4=Leach |first4=Natalia T. |last5=Bashford |first5=Michael T. |last6=Goldwaser |first6=Tamar |last7=Chen |first7=Emily |last8=Sparks |first8=Teresa N. |last9=Reddi |first9=Honey V. |last10=Rajkovic |first10=Aleksandar |last11=Dungan |first11=Jeffrey S. |date=2021-10-01 |title=Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG) |url=https://www.gimjournal.org/article/S1098-3600(21)05120-0/fulltext |journal=Genetics in Medicine |language=English |volume=23 |issue=10 |pages=1793–1806 |doi=10.1038/s41436-021-01203-z |issn=1098-3600 |pmid=34285390|pmc=8488021 }}</ref><ref>{{Cite web |title=Carrier Screening |url=https://www.acog.org/womens-health/faqs/carrier-screening |access-date=2025-03-10 |website=www.acog.org |language=en}}</ref>

=== Prenatal screening ===
[[Prenatal testing|Prenatal screening]] is can be conducted on pregnant females to test for a number of genetic conditions.  It is more commonly used to test for aneuploidy (for example, Down syndrome or trisomy 21), but can also be used to detect X-linked recessive or X-linked dominant disorders (for example, [[Fragile X syndrome|fragile X-syndrome]]).  Prenatal screening involves maternal [[blood test]]s and [[ultrasound]] to defect such defects in the developing [[fetus]].  This can confirm the diagnosis of a genetic condition, allowing parents to prepare or consider [[Abortion|terminating the pregnancy]].<ref>{{cite journal |last1=Cuckle |first1=Howard |last2=Maymon |first2=Ron |date=February 2016 |title=Development of prenatal screening—A historical overview |journal=Seminars in Perinatology |volume=40 |issue=1 |pages=12–22 |doi=10.1053/j.semperi.2015.11.003 |pmid=26764253}}</ref><ref>{{Cite web |title=Prenatal testing: Is it right for me? |url=https://www.mayoclinic.org/healthy-lifestyle/pregnancy-week-by-week/in-depth/prenatal-testing/art-20045177 |access-date=2025-03-10 |website=Mayo Clinic |language=en}}</ref><ref>{{Cite web |title=What Is Fragile X Syndrome (FXS)? |url=https://my.clevelandclinic.org/health/diseases/5476-fragile-x-syndrome |archive-url=http://web.archive.org/web/20250213093459/https://my.clevelandclinic.org/health/diseases/5476-fragile-x-syndrome |archive-date=2025-02-13 |access-date=2025-03-10 |website=Cleveland Clinic |language=en}}</ref>

=== Newborn screening ===
Newborn screening is conducted on infants less than a week old to test for a variety of genetic disorders, specifically those with high morbidity and mortality rates to enable early intervention.  Newborn screening is conducted by analyzing the biochemistry of a spot of dried blood (often obtained via a [[Neonatal heel prick|heel prick test]]).  This form of screening is also used to detect endocrine and metabolic disorders.<ref>{{Cite journal |last1=Anderson |first1=R. |last2=Rothwell |first2=E. |last3=Botkin |first3=J. R. |date=2011 |title=Newborn Screening |journal=Annual Review of Nursing Research |language=en |volume=29 |issue=1 |pages=113–132 |doi=10.1891/0739-6686.29.113 |issn=0739-6686 |pmc=7768912 |pmid=22891501}}</ref><ref>{{Cite journal |last1=Ding |first1=Si |last2=Han |first2=Lianshu |date=2022-10-24 |title=Newborn screening for genetic disorders: Current status and prospects for the future |journal=Pediatric Investigation |language=en |volume=6 |issue=4 |pages=291–298 |doi=10.1002/ped4.12343 |pmid=36582269 |pmc=9789938 |issn=2574-2272 }}</ref>

==Y-linked inheritance ==
{{Main|Y linkage}}

=== The Y chromosome ===
[[File:Human_male_karyotpe_high_resolution_-_Chromosome_Y.png|thumb|This image depicts a [[karyotype]]. The Y chromosome is at the bottom right in a red box. Note how it is notably smaller than the X chromosome, the chromosome to its left.]]The [[Y chromosome]] is composed of approximately 59 million base pairs and 200 genes, entailing approximately 66 protein-coding genes.<ref name=":93">{{Cite journal |last=Dever |first=Jennifer |date=2024 |title=Female Biology |url=https://core.ac.uk/reader/596873190#page=61 |journal=All USF Faculty Authored Books |pages=54–107}}</ref><ref name=":24">{{Cite web |date=2024-09-22 |title=6.5: Y-Linked Genes |url=https://bio.libretexts.org/Courses/City_College_of_San_Francisco/Introduction_to_Genetics/06:_Sex_Chromosomes__Sex_Linkage/6.05:_Y-Linked_Genes |access-date=2025-02-28 |website=Biology LibreTexts |language=en}}</ref><ref name=":63">{{Cite journal |last=Singh |first=Natasha Ramroop |date=2023-02-01 |title=10.5 Y-Linked Genes |url=https://opengenetics.pressbooks.tru.ca/chapter/y-linked-gene/ |journal=Introduction to Genetics |language=en-ca}}</ref> Since only biological males possess the Y chromosome, it is essential in male [[Sexual differentiation in humans|sexual differentiation]], which results in the production of male sex hormones that lead to the development of male sex organs, reproduction, fertility, and [[spermatogenesis]], commonly known as sperm production.<ref name=":24" /><ref name=":44">{{Cite journal |last=Stern |first=Curt |year=1957 |title=The Problem of Complete Y-Linkage in Man |journal=American Journal of Human Genetics |language=en |volume=9 |issue=3 |pages=147–166 |pmid=13469791 |pmc=1931892 }}</ref><ref>{{Cite web |last1=Zhao |first1=Roseanne F. |title=The Y chromosome: beyond gender determination |url=https://www.genome.gov/27557513/the-y-chromosome-beyond-gender-determination#:~:text=The%20presence%20or%20absence%20of,of%20the%20male%20reproductive%20system. |access-date=2025-02-28 |website=www.genome.gov |language=en}}</ref> Additionally, due to the small length of the Y chromosome in comparison to the X chromosome, recombination is mostly suppressed, and thus it remains relatively distinct from the X chromosome, maintaining important genes for male fertility and sexual differentiation.<ref name=":93" /> Particularly, the SRY gene on the Y chromosome is known to be involved in [[Sex-determination system|sex determination]].<ref name=":93" /> As well, AZF, azoospermia factor region encodes for 16 proteins, and are thus  related to the production of sperm.<ref name=":11">{{Cite journal |last1=Li |first1=Zheng |last2=Haines |first2=Christopher J |last3=Han |first3=Yibing |date=2008-04-01 |title="Micro-deletions" of the human Y chromosome and their relationship with male infertility |url=https://www.sciencedirect.com/science/article/abs/pii/S1673852708600272 |journal=Journal of Genetics and Genomics |volume=35 |issue=4 |pages=193–199 |doi=10.1016/S1673-8527(08)60027-2 |pmid=18439975 |issn=1673-8527|url-access=subscription }}</ref>

The Y chromosome has a highly repetitive sequence, and thus had many gaps that were not able to be sequenced until recently.<ref name=":93" /> Based on advances in the Makova Lab at Penn State and Phillippy at the Human Genome Research Institute, they successfully filled in the missing sequence gaps.<ref name=":93" />

=== The SRY gene ===
The [[Sex-determining region Y protein|SRY gene]], being the sex-determining region of the Y chromosome, gives the genetic information required for the body to code for proteins that are involved in male sexual differentiation.<ref name=":72">{{Cite web |title=SRY gene: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/gene/sry/ |access-date=2025-03-05 |website=medlineplus.gov |language=en}}</ref> The expression of the SRY gene is regulated via a myriad of [[transcription factor]]s, which is a protein that can bind to genes of interest and increase or decrease their expression.<ref name=":72" /> Specific to SRY these include, Six1, WT1, and Gata4.<ref name=":93" /> SRY expression is regulated spatially and temporally in a strict manner.<ref name=":93" /> The SRY gene encodes a transcription factor called the Testes Determining Factor (Tdf), and Tdf binds to and activates another gene called [[SOX9|Sox9]].<ref name=":93" /> Sox9 then codes a transcription factor that leads to the development of the testes via many downstream pathways that ultimately result in the targeting of Sertoli cell which is where sperm is produced and the Lydig cell, also called testicular somatic cells, which is where the androgen hormone is produced, that is essential for male sexual differentiation.<ref name=":93" /><ref name=":10">{{Cite journal |last1=Hughes |first1=Jennifer F. |last2=Page |first2=David C. |date=2015-11-23 |title=The Biology and Evolution of Mammalian Y Chromosomes |url=https://www.annualreviews.org/content/journals/10.1146/annurev-genet-112414-055311;jsessionid=jl5g0P_7Qq7FJRUZp_jH3I5T5uSbweG6MvJOfkkx.ip-10-241-10-89 |journal=Annual Review of Genetics |language=en |volume=49 |issue= |pages=507–527 |doi=10.1146/annurev-genet-112414-055311 |pmid=26442847 |hdl=1721.1/108037 |issn=0066-4197|hdl-access=free }}</ref> Therefore, SRY expression leads to testis development in biological XY males, and absence of SRY in biological XX females, leads to ovary development.<ref name=":04">{{Cite journal |last1=Okashita |first1=Naoki |last2=Tachibana |first2=Makoto |date=2021-09-28 |title=Transcriptional Regulation of the Y-Linked Mammalian Testis-Determining Gene SRY |url=https://karger.com/sxd/article-abstract/15/5-6/351/829210/Transcriptional-Regulation-of-the-Y-Linked?redirectedFrom=fulltext |journal=Sexual Development |volume=15 |issue=5–6 |pages=351–359 |doi=10.1159/000519217 |pmid=34583357 |issn=1661-5425}}</ref>

[[XY gonadal dysgenesis|Swyer syndrome]], also known as complete gonadal dysgenesis or pure gonadal dysgenesis, is a condition that impairs the process of sexual differentiation in males.<ref name=":72" /> Male individuals with this condition have a normal XY [[genotype]], yet due to the impairment of the SRY gene, the protein critical in male sexual determination is non-functional or is not produced at all.<ref name=":72" /> As a result, male sexual differentiation is prevented, and an affected individual will lack male sexual characteristics such as gonads, and will instead develop biological female-typical sex characteristics, such as a uterus, fallopian tubes, etc.<ref name=":72" />

=== Y-linked inheritance ===
Y-linked inheritance, also known as Holandric inheritance, refers to genes that are inherited via the Y chromosome.<ref name=":5">{{cite book |last1=Rodakis |first1=G.C. |title=Brenner's Encyclopedia of Genetics |date=2013 |isbn=978-0-08-096156-9 |pages=238–239 |chapter=Paternal Inheritance |doi=10.1016/B978-0-12-374984-0.01125-6 |quote=Male-specific chromosomes provide the most straightforward cases of strict paternal inheritance. In the XY/XX sex chromosome system of mammals, sex is a paternally inherited factor because of the action of a single Y-linked gene. In humans, this gene is the SRY (sex-determining region Y), which encodes a transcription factor required for testis determination.}}</ref> In other words, Y-linked inheritance involves genes that are only carried on the Y chromosome, also known as [[Y linkage|Y-linked genes]].
[[File:Rodoslov_Y-vezane_osobine.png|thumb|This is a [[Pedigree chart|pedigree]] representing the offspring of individuals. Squares represent males, and circles represent females. More specifically, this pedigree depicts Y-linked or Holandric inheritance. This shows how Y-linked disorders will be passed to all son offspring, and will not be passed down at all to daughters, due to their absence of chromosome.]]
Inheritance of Y-linked genes can occur in two ways: complete inheritance and incomplete inheritance.<ref name=":42">{{Cite journal |last=Stern |first=Curt |date=September 1957 |title=The Problem of Complete Y-Linkage in Man |journal=American Journal of Human Genetics |language=en |volume=9 |issue=3 |pages=147–166 |pmc=1931892 |pmid=13469791}}</ref> Complete Y-linkage results when a gene is only found on a certain area on the Y chromosome either because there is no [[allele]] i.e. a copy of that gene, on the X chromosome or because it does not exchange with the X chromosome's allele.<ref name=":42" /> Complete Y linkage of heterogamous organisms can result in the following possible outcomes:

* Traits that only occur in males <ref name=":42" /><ref name=":5" />
* Y-linked disorders of males will be passed on to all sons <ref name=":42" /><ref name=":5" />
* The daughters of affected men being [[Phenotype|phenotypically]] normal, i.e. 'normal' presenting, and not having affected offspring <ref name=":42" /><ref name=":5" />

Conversely, incomplete Y linkage is when traits on a gene cross-over and exchange information between the X and Y chromosome.<ref name=":42" />

=== Y-linked disorders ===

==== Overview ====
The first few Y-linked inheritance cases were recognized in the early 20th century, with initial theories proposing certain traits were passed exclusively from father to son.<ref>Scientific American. (2023). The complete human Y chromosome marks an opportunity to move away from stigma</ref> However, it was not until genetic advancements and cytogenetic techniques that enabled researchers to have a better understanding of the Y chromosome in greater detail.<ref>{{cite journal | author = Jobling M. A., Tyler-Smith C. | year = 2017 | title = Human Y-chromosome variation in the genome-sequencing era | url = | journal = Nature Reviews Genetics | volume = 18 | issue = 8| pages = 485–497 | doi = 10.1038/nrg.2017.36 | pmid = 28555659 | hdl = 2381/40490 | hdl-access = free }}</ref> When scientist began mapping the Y chromosome and identifying traits that followed a paternal lineage, it became evident that certain genetic conditions were linked to the male-specific chromosome. The identification of Y-linked inheritance marked a significant milestone in laying the groundwork for expanding research into male-specific conditions. Further understanding led to exploration of developmental disorders, allowing of diagnostic and therapeutic strategies to be explored in medical genetics. Eventually, ongoing investigations into Y chromosome revealed the broader picture in human biology, evolution and disease susceptibility.<ref>{{cite journal | author = Hughes J. F. | display-authors = etal | year = 2020 | title = A Y chromosome assembly for the domestic goat and insight into mammalian sex chromosome evolution | url = | journal = Nature Communications | volume = 11 | issue = | page = 2539 }}</ref>

==== Hypertrichosis ====
[[Hypertrichosis]] is a genetic condition that results in the excessive growth of hair on a specific area of the body, that is abnormal for the age, sex or race of an individual.<ref name=":8">{{Cite web |title=JCDR - Biological anthropology, Hairy ears, Human biology, Human genetics, Pedigree analysis, Penetrance, Population variation, Y-linkage |url=https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2018&volume=12&issue=3&page=AE01&issn=0973-709x&id=11295 |access-date=2025-03-07 |website=jcdr.net}}</ref> Specifically, hypertrichosis centralized to the outer ear, also known as the auricle, is a Y-linked disordered, commonly referred to as hypertrichosis pinnae auris.<ref name=":8" /> Since hypertrichosis pinnae auris is a Y-linked disorder, this means only biological males and subsequent male offspring can be affected by this disorder.<ref name=":8" /> Tommasi C. was crucial in determining the Y-linked origin of this disorder, by creating a pedigree that elicited holandric inheritance.<ref name=":8" /> Conversely, hypertrichosis cannot be confused with [[Hirsutism|Hirustism]], which is characterized by excessive androgen sensitive hair growth, and thus is most often diagnosed in women and children that tend to have male-typical hair patterns.

Considered to be relatively rare as the congenital form is classified in 2 categories; generalized hypertrichosis (CGH) and localized hypertrichosis (CLH).<ref name="rizz">{{Cite journal |title=  Congenital generalized hypertrichosis: the skin as a clue to complex malformation syndromes|doi= 10.1186/s13052-015-0161-3|doi-access= free|pmid= 26242548|volume= 41|pmc= 4526284|year= 2015|author= Pavone P, Praticò AD, Falsaperla R, Ruggieri M, Zollino M, Corsello G, Neri G|journal= Ital J Pediatr|article-number= 55}}</ref>[[File:Hypertrichosis.jpg|thumb|The image depicts hypertrichosis, specifically overgrowth of chest hair in varying places]] CGH is seen amongst individuals with excessive hair growth that cover most of the body while CLH affects a specific area of the body, typically a patch of area. Although the incidence is unknown, it seen that CGH is extremely rare with very few cases documented worldwide compared to CLH is more commonly seen.<ref name="rizz" /> Now acquired hypertrichosis is a type that can develop later in life, typically from medicinal triggers or from underlying medical conditions.<ref name="rizz" />

==== Webbed toes ====
Webbing of the toes is the result of premature arrested development in the fetal stage.<ref name=":9">{{Cite web |title=Y Linked Inheritance |url=https://unacademy.com/content/neet-ug/study-material/biology/y-linked-inheritance/ |access-date=2025-03-07 |website=Unacademy |language=en-US}}</ref> The premature arrest of development results in second and third digit fusion of the skin.<ref name=":9" /> The Y-linked trait of [[webbed toes]] causes a skin connection between the second and third digit.<ref name=":63"/> Research studies based in a pedigree analysis have shown that webbed toes follow holandric inheritance in biological males.<ref name=":9" /><ref name=":8" />[[File:Webbed_toes_b4.jpg|thumb|This image depicts webbed toes, whereby there is a connection of the second and third digits.]]

Considered to be the most prevalent congenital limb malformation where the occurrence is 1 in 2000-3000 in live births, accounting for 20% of congenial hand malformation.<ref>{{cite journal | url=https://emedicine.medscape.com/article/1244420-overview?utm_ | title=Syndactyly: Practice Essentials, Etiology, Epidemiology | date=March 2024 }}</ref> The condition is more frequently seen in males where it is a 2:1 ratio for male-to-females. Syndactyl can present as an "isolated anomaly" where it occurs as a standalone condition often with no known cause.<ref>{{cite journal | author = Mahindroo S, Tabaie S | year = 2023 | title = Syndactyly in the Pediatric Population: A Review of the Literature | url = | journal = Cureus | volume = 15 | issue = 3| article-number = e36118 | doi = 10.7759/cureus.36118 | pmid = 36937133 | pmc = 10016737 | doi-access = free }}</ref> In other scenarios, syndactyl is a features amongst other symptoms of a larger genetic disorder (ie. Holt-Oram syndrome).

=== Infertility in biological males ===

==== Overview ====
Y-linked genes responsible for [[spermatogenesis]] can result in male infertility, characterized by [[azoospermia]],<ref name=":02">{{Cite web |title=Y chromosome infertility: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/y-chromosome-infertility/#causes |access-date=2025-02-07 |website=medlineplus.gov |language=en}}</ref><ref name=":12">{{Cite journal |last1=Colaco |first1=Stacy |last2=Modi |first2=Deepak |date=2018-02-17 |title=Genetics of the human Y chromosome and its association with male infertility |journal=Reproductive Biology and Endocrinology |language=en |volume=16 |issue=1 |page=14 |doi=10.1186/s12958-018-0330-5 |doi-access=free |issn=1477-7827 |pmc=5816366 |pmid=29454353}}</ref> or hypo-fertility, which is the hindered production of sperm.<ref name=":5" /> Azoospermia is the absence of functional sperm in male ejaculate due to issues in sperm motility or lack of sperm production.<ref name=":12" /> As a result, Y-chromosome linked infertility is characterized as the inability to fertilize an egg and produce children.<ref name=":02" /> Sperm infertility results from the failure of the sperm to mature or a disfigured sperm that is not able to travel and fertilize an egg effectively.<ref name=":02" />

==== Prevalence of Y chromosome Infertility ====
Male infertility affects 1 in 20 men, at 0.05% and primary spermatogenic failure accounts for a large portion of these cases.<ref name=":11" /> More specifically, Y chromosome infertility is relatively rare at a 0.03-0.05% frequency.<ref name=":02" />

==== Etiology of Y chromosome Infertility ====
Mutations to the male-specific region of the Y chromosome (MSY) are typically the cause of spermatogenic failure, which is the reduced or absent sperm production in semen.<ref>{{Cite journal |last1=Hughes |first1=Jennifer F. |last2=Page |first2=David C. |date=2015-11-23 |title=The Biology and Evolution of Mammalian Y Chromosomes |url=https://www.annualreviews.org/content/journals/10.1146/annurev-genet-112414-055311;jsessionid=jl5g0P_7Qq7FJRUZp_jH3I5T5uSbweG6MvJOfkkx.ip-10-241-10-89 |journal=Annual Review of Genetics |language=en |volume=49 |issue=2015 |pages=507–527 |doi=10.1146/annurev-genet-112414-055311 |pmid=26442847 |hdl=1721.1/108037 |issn=0066-4197|hdl-access=free }}</ref> More specifically, deletions in long arm of the Y chromosome are associated with spermatogenic failure, as well some paternal lineages of the Y chromosome are associated with reduced sperm counts.<ref name=":122">{{Cite journal |last1=Krausz |first1=Csilla |last2=Forti |first2=G. |last3=McElreavey |first3=Ken |date=2003 |title=The Y chromosome and male fertility and infertility |url=https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2605.2003.00402.x |journal=International Journal of Andrology |language=en |volume=26 |issue=2 |pages=70–75 |doi=10.1046/j.1365-2605.2003.00402.x |pmid=12641824 |issn=1365-2605}}</ref> Y chromosome deletions are determined as the most frequent cause of genetic azoopermia, however other instances such as rearrangements, deletions and duplications may contribute to infertile biological males.<ref name=":122" />

== Sex chromosome aneuploidy ==
Thus far, this article has discussed the patterns of inheritance of sex-linked genes / traits in diploid organisms with the canonical XX (female) or XY (male) genotype.  However, there exists a very small fraction of the human population with [[aneuploidy]] (an abnormal number) of the sex chromosomes.<ref name=":15">{{Citation |last1=Skuse |first1=David |title=Chapter 24 - Sex chromosome aneuploidies |date=2018-01-01 |journal=Handbook of Clinical Neurology |volume=147 |pages=355–376 |editor-last=Geschwind |editor-first=Daniel H. |url=https://linkinghub.elsevier.com/retrieve/pii/B9780444632333000245 |access-date=2025-03-27 |series=Neurogenetics, Part I |publisher=Elsevier |doi=10.1016/b978-0-444-63233-3.00024-5 |last2=Printzlau |first2=Frida |last3=Wolstencroft |first3=Jeanne |pmid=29325624 |isbn=978-0-444-63233-3 |editor2-last=Paulson |editor2-first=Henry L. |editor3-last=Klein |editor3-first=Christine|url-access=subscription }}</ref>  This includes monosomy of the X-chromosome (XO genotype), also called Turner syndrome, in which up to 0.04% of females are born with one X-chromosome as supposed to two. Turner syndrome can result in developmental and health-related issues, including short stature, problems with ovarian development, and congenital heart defects.<ref>{{Cite web |title=A genetic disorder that affects females-Turner syndrome - Symptoms & causes |url=https://www.mayoclinic.org/diseases-conditions/turner-syndrome/symptoms-causes/syc-20360782 |access-date=2025-03-27 |website=Mayo Clinic |language=en}}</ref>  Females can also present with trisomy of the X-chromosome, or the XXX genotype, which can result in tall stature, and in some cases, delayed development of speech, language, and motor functions.<ref>{{Cite web |title=Trisomy X: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/trisomy-x/#:~:text=Description,causes%20no%20unusual%20physical%20features. |access-date=2025-03-27 |website=medlineplus.gov |language=en}}</ref>  Sex chromosome aneuploidy which results in male development includes the XXY genotype, and very rarely, the XXYY genotype.<ref name=":15" />  XXY, also known as Klinefelter syndrome, can result in a variety of symptoms, the severity of which is widely variable.  Symptoms may include tall stature and reduced testosterone production, leading to delayed or incomplete development of male sex characteristics.  Those with Klinefelter syndrome will also be at greater risk for developing of learning disorders, Attention-Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and metabolic syndromes.<ref>{{Cite web |title=Klinefelter syndrome: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/klinefelter-syndrome/ |access-date=2025-03-27 |website=medlineplus.gov |language=en}}</ref>  Males with the XXYY genotype exhibit similar but often more severe symptoms to Klinefelter syndrome, and are infertile.<ref>{{Cite web |title=48,XXYY syndrome: MedlinePlus Genetics |url=https://medlineplus.gov/genetics/condition/48xxyy-syndrome/ |access-date=2025-03-27 |website=medlineplus.gov |language=en}}</ref>

It is notable that, while sex chromosome aneuploidy is not an inherited condition (and instead arises due to [[nondisjunction]] of the sex chromosomes during meiosis) in individuals with an abnormal number of sex chromosomes, the patterns of inheritance and expression of sex-linked genes and traits will vary from those discussed for XX and XY individuals.  This is largely due to the dosage imbalance of one or both of the sex-chromosomes.  For instance, a XO female with Turner syndrome would be affected by X-linked recessive traits in the same way as XY males, lacking a second X-chromosome encoding a dominant allele to mask the recessive phenotype.  Moreover, inactivation of all but one X-chromosomes by Xist, and the fact that nondisjunction during meiosis can lead to aneuploidy in either all or some of the body's cells, can lead to genetic mosaicism and intermediate phenotypes.<ref name=":15" />

==Sex-linkage in animals==
Most mammals, including humans, use the XY sex determination system and thus follow the same patterns of sex-linked inheritance discussed herein so long as the sex chromosomes are present in normal ploidy (diploidy).<ref>{{Cite web |title=Genetic Mechanisms of Sex Determination |url=https://www.nature.com/scitable/topicpage/genetic-mechanisms-of-sex-determination-314/ |access-date=2025-03-27 |website=www.nature.com |language=en}}</ref>  However, patterns of inheritance of sex-linked traits differ in animals that use [[sex-determination systems]] other than [[XY sex-determination system|XY]].  For instance, in the [[ZW sex-determination system]] used by birds, the mammalian pattern is reversed, since the male is the homogametic (ZZ) and the female is [[heterogametic]] (ZW).<ref>{{Cite journal |last1=Bachtrog |first1=Doris |last2=Kirkpatrick |first2=Mark |last3=Mank |first3=Judith E. |last4=McDaniel |first4=Stuart F. |last5=Pires |first5=J. Chris |last6=Rice |first6=William |last7=Valenzuela |first7=Nicole |date=2011-09-01 |title=Are all sex chromosomes created equal? |url=https://www.cell.com/trends/genetics/abstract/S0168-9525(11)00066-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0168952511000667%3Fshowall%3Dtrue |journal=Trends in Genetics |language=English |volume=27 |issue=9 |pages=350–357 |doi=10.1016/j.tig.2011.05.005 |issn=0168-9525 |pmid=21962970|url-access=subscription }}</ref>

''Drosophila melanogaster'', a common model organism in genetics and developmental biology, carry both the X and Y sex chromosomes.  However, the rules of sex determination are not the same as in humans and other placental mammals in which sex is determined by the presence or absence of the Y-chromosome.  Instead, sex is determined by the ratio of X-chromosomes to autosomes, the X:A ratio.  A ratio of 1:2 results in male development, while a ratio of 1:1 results in female development.  Drosophila have two autosomes, thus XO and XY flies are males (1X:2A), while XX flies are females (2X:2A).  As the X-chromosome makes up a far more significant portion of the genome, far more genes are sex-linked in Drosophila as compared to humans.<ref>{{Citation |last=Gilbert |first=Scott F. |title=Chromosomal Sex Determination in Drosophila |date=2000 |work=Developmental Biology. 6th edition |url=https://www.ncbi.nlm.nih.gov/books/NBK10025/ |access-date=2025-03-27 |publisher=Sinauer Associates |language=en}}</ref>  Moreover, the mechanism of [[Sex-chromosome dosage compensation|dosage compensation]] in Drosophila is not X-inactivation in females, but the two-fold upregulation of expression of genes encoded on the X-chromosome in males.<ref>{{Cite journal |last1=Conrad |first1=Thomas |last2=Akhtar |first2=Asifa |date=18 January 2012 |title=Dosage compensation in Drosophila melanogaster: epigenetic fine-tuning of chromosome-wide transcription |journal=Nature Reviews Genetics |volume=13 |issue=2 |pages=123–134|doi=10.1038/nrg3124 |pmid=22251873 |doi-access=free }}</ref>

Much of the scientific knowledge on sex-linked traits was derived from observations and experimental evidence made in non-human animals.  Some of the discoveries instrumental to forming this body of knowledge include:
* The first sex-linked gene ever discovered was the "lacticolor" [[X-linked recessive]] gene in the moth ''[[Abraxas grossulariata]]'' by [[Leonard Doncaster]].<ref>{{cite journal | author = Doncaster L., Raynor G.H. | year = 1906 | title = Breeding experiments with Lepidoptera | url = | journal = Proceedings of the Zoological Society of London | volume = 1 | issue = 1–2| pages = 125–133 | doi = 10.1111/j.1469-7998.1906.tb08425.x }}</ref>
* [[White (mutation)|White eyes]] in ''[[Drosophila melanogaster]]'' flies was one of the earliest sex-linked [[gene]]s discovered.<ref>{{cite journal | author = Morgan T.H. | year = 1910 | title = Sex-limited inheritance in Drosophila | url = | journal = Science | volume = 32 | issue = 812| pages = 120–122 | doi = 10.1126/science.32.812.120 | pmid = 17759620 | bibcode = 1910Sci....32..120M }}</ref>
* Fur color in domestic [[cat]]s: [[Calico cat|Calico]] or [[tortoiseshell cat]]s are nearly always female because these cats receive one allele for black (or gray) fur colour on one inherited X-chromosome, and one allele for orange fur colour on the other X-chromosome.  White fur colour is located on an autosome.  Thus, only females and XXY males can have this fur coloration.<ref>{{Cite web |title=Table:Calico and Black and Orange Tortoiseshell Cats |url=https://www.merckvetmanual.com/multimedia/table/calico-and-black-and-orange-tortoiseshell-cats |access-date=2025-03-10 |website=Merck Veterinary Manual |language=en-US}}</ref>

== History ==
[[File:Sex-linked_inheritance.svg|thumb|356x356px|Experimental cross performed by [[Thomas Hunt Morgan]], illustrating the X-linked inheritance of [[White (mutation)|white-eyed]] mutation in [[Drosophila|fruit flies]]<ref>[[Thomas Hunt Morgan|Morgan, Thomas Hunt]] 1919. ''The physical basis of heredity''. Philadelphia: J.B. Lippincott Company.</ref>]]

=== Discovery of sex chromosomes ===
The relationship between sex [[chromosome]]s and Mendelian inheritance was first discovered by Nettie Stevens.<ref name=":93" /> Steven's was influenced by McClung's work highlighting, that some insect species, the difference in chromosome counts possibly determined whether cells develop into males or females.<ref name=":21">{{Cite web |title=Studies in Spermatogenesis (1905), by Nettie Maria Stevens {{!}} Embryo Project Encyclopedia |url=https://embryo.asu.edu/pages/studies-spermatogenesis-1905-nettie-maria-stevens |access-date=2025-04-04 |website=embryo.asu.edu |language=en}}</ref> In Steven's study called ''Studies in spermatogenesis,'' she found that biological females carry two X chromosomes, whereas males carry one X and a smaller Y chromosome.<ref name=":93" /> By identifying the male unique role of the Y chromosome, Stevens was able to confirm a chromosomal role in [[Sex-determination system|sex determination]].<ref name=":93" /> She had done this by using a microscope ''Tenebrio molitor,'' mealworm beetles, to observe that there were 20 chromosome in both the male and females. However, in the males, she had found that the 20th chromosome was significantly smaller than the other 19 chromosomes. Steven's continued ''Studies in spermatogenesis,'' and found the same pattern in 18 other species. Additionally, her work contradicted the common theories that attributed to sex determination, including role of environmental factors.<ref name=":21" />

=== Discovery of X-linked inheritance ===
Red-green colour blindness was the first described on paper, in 1794 by [[John Dalton]], who was affected by the disorder himself.<ref>{{Cite journal |last1=Hunt |first1=David M. |last2=Dulai |first2=Kanwaijit S. |last3=Bowmaker |first3=James K. |last4=Mollon |first4=John D. |date=1995-02-17 |title=The Chemistry of John Dalton's Color Blindness |url=https://www.science.org/doi/10.1126/science.7863342 |journal=Science |language=en |volume=267 |issue=5200 |pages=984–988 |doi=10.1126/science.7863342 |pmid=7863342 |bibcode=1995Sci...267..984H |issn=0036-8075|url-access=subscription }}</ref> However, its recognition of its X-linked inheritance characteristic was only established later. The X-chromosome was discovered in 1890 by [[Hermann Henking]],<ref>{{Cite book |last=Schwartz |first=James |title=In pursuit of the gene: from Darwin to DNA |date=2009 |publisher=Harvard Univ. Press |isbn=978-0-674-03491-4 |edition=1. paperback |location=Cambridge, Mass.}}</ref> which he discovered while studying [[spermatocyte]] divisions of the firebug. He found that one chromosome behaved different from all the others, and did not divide during [[meiosis]]. Instead, he found that it went into one of the two germ cells. This cell that did not divide became known as the X-chromosome.<ref>{{Cite journal |last1=Paliulis |first1=Leocadia |last2=Fabig |first2=Gunar |last3=Müller-Reichert |first3=Thomas |year=2023 |title=The X chromosome still has a lot to reveal - revisiting Hermann Henking's work on firebugs |url=https://cob.silverchair-cdn.com/cob/content_public/journal/jcs/136/4/10.1242_jcs.260998/3/jcs260998.pdf?Expires=1746799288&Signature=1pnVk4ohHePm3yicfosqPu~j6WZs4lqDC1Jdfxdz-UPj8hONCYCZeMSnqMGkJQZKieB1GlcFrU9VSnA2LDuZ2mDTrfco6QSVuTglbgF-9~J8SjsWSw7OYNQd7SWhdWQcnLnkjDMqzw7p7fhLTt-E-5uVzBSyd4EXrc7oSxSmzUAbbNc~MvwGtxbZUu8AEosIcMdZOAgHG8sC9JK1HUYJT8WXGDXmkTDaUT1hAZszYjxOS1qBTicNC0Jxe6tyMI4R0pSFPKgIOCzNiFPqK~T9lL5dhHnErOz5t-aycb2uPT0ErYuTyYIiR-1oamcMkXvMTiLAvsuUaMTYOU8L--g6Lw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA |journal=Journal of Cell Science |volume=136 |issue=4 |publisher=The Company of Biologists Ltd |doi=10.1242/jcs.260998|pmid=36790431 |page=jcs260998 }}</ref> Then in 1910, [[Thomas Hunt Morgan]] discovered an X-linked mutation on a [[Drosophila]],<ref>{{Cite journal |last=Green |first=M M |date=2010-01-01 |title=2010: A Century of Drosophila Genetics Through the Prism of the white Gene |journal=Genetics |language=en |volume=184 |issue=1 |pages=3–7 |doi=10.1534/genetics.109.110015 |issn=1943-2631 |pmc=2815926 |pmid=20061564}}</ref> who then conducted experiments and observations to understand the X-linked inheritance. He observed a white-eye male fruit fly, which is rare, and through cross-breeding experiments, he found that the mutation was inherited differently in males and females. He found that males, who had the only one X-chromosomes displayed the condition, if the mutated gene was present.<ref>{{Cite web |title="Sex Limited Inheritance in Drosophila" (1910), by Thomas Hunt Morgan {{!}} Embryo Project Encyclopedia |url=https://embryo.asu.edu/pages/sex-limited-inheritance-drosophila-1910-thomas-hunt-morgan |access-date=2025-04-04 |website=embryo.asu.edu}}</ref>

=== Discovery of X-inactivation ===
In 1961, [[Mary Lyon]] proposed that one of the two X chromosomes in female mammalian cells would experience random inactivation (see [[X-inactivation|X-chromosome inactivation]]) in the [[Embryo|early embryonic stage]].<ref>{{cite journal |last1=Disteche |first1=Christine M. |last2=Berletch |first2=Joel B. |title=X-chromosome inactivation and escape |journal=Journal of Genetics |date=December 2015 |volume=94 |issue=4 |pages=591–599 |doi=10.1007/s12041-015-0574-1 |pmc=4826282 |pmid=26690513 }}</ref> According to her hypothesis, both males and females should have one single X chromosome that is active. This enhanced the understanding of the fundamental mechanisms of X-linked inheritance.

== Related terms ==
It is important to distinguish between sex-linked characters, which are controlled by genes on sex chromosomes, and two other categories.<ref>[[Conway Zirkle|Zirkle, Conway]] (1946). The discovery of sex-influenced, sex limited and sex-linked heredity. In Ashley Montagu M.F. (ed) ''Studies in the history of science and learning offered in homage to George Sarton on the occasion of his sixtieth birthday''. New York: Schuman, p167–194.</ref>

=== Sex-influenced traits ===
Sex-influenced or sex-conditioned traits are phenotypes affected by whether they appear in a male or female body.<ref name="King">King R.C; Stansfield W.D. & Mulligan P.K. 2006. ''A dictionary of genetics''. 7th ed, Oxford University Press. {{ISBN|0-19-530761-5}}</ref> Even in a homozygous dominant or recessive female the condition may not be expressed fully. Example: [[baldness]] in humans.

=== Sex-limited traits ===
These are characters only expressed in one sex. They may be caused by genes on either autosomal or sex chromosomes.<ref name="King" /> Examples: female sterility in ''Drosophila''; and many [[Polymorphism (biology)|polymorphic]] characters in insects, especially in relation to [[mimicry]]. Closely linked genes on autosomes called "[[supergene]]s" are often responsible for the latter.<ref>{{cite journal |author1=Mallet J. |author1-link=James Mallet |author2=Joron M. |year=1999 |title=The evolution of diversity in warning color and mimicry: polymorphisms, shifting balance, and speciation |journal=Annual Review of Ecology and Systematics |volume=30 |issue=1 |pages=201–233 |bibcode=1999AnRES..30..201M |doi=10.1146/annurev.ecolsys.30.1.201}}</ref><ref>[[E. B. Ford|Ford E. B.]] (1965) ''Genetic polymorphism''. p17-25. MIT Press 1965.</ref><ref>{{cite journal |vauthors=Joron M, Papa R, Beltrán M, etal |year=2006 |title=A conserved supergene locus controls colour pattern diversity in Heliconius butterflies |journal=PLOS Biol. |volume=4 |issue=10 |article-number=e303 |doi=10.1371/journal.pbio.0040303 |pmc=1570757 |pmid=17002517 |doi-access=free}}</ref>

==See also==
* [[X-linked dominant inheritance]]
* [[X-linked recessive inheritance]]
* [[Genetic epidemiology]] 
* [[List of genetic disorders]]

==References==
{{Reflist}}

{{X-linked disorders}}
{{Authority control}}

[[Category:Genetics]]
[[Category:Sex|linkage]]